Risk-Adapted Intravenous Melphalan with Adjuvant Thalidomide and Dexamethasone for Newly Diagnosed Untreated Patients with Systemic AL Amyloidosis: Interim Report of a Phase II Trial
Year: 2004
Type: book-chapter
Source: CRC Press eBooks
Parent work: Amyloid and Amyloidosis
Authors: Rl Comenzo, P. Zhou, L. Reich, S. Costello, A. Quinn, S. Fircanis, L. Drake, C. Hedvat, J. Teruya-Feldstein, Da Filippa, M. Fleisher
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4253787696
